North America Insulin Pens Market Analysis, Size, and Share by 2027

North America Insulin Pens Market to 2027 - Regional Analysis and Forecasts By Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography

Historic Data: 2016-2017 | Base Year: 2018 | Forecast Period: 2019-2027
  • Status : Published
  • Report Code : TIPRE00006290
  • Category : Life Sciences
  • No. of Pages : 114
  • Available Report Formats : pdf-format excel-format
  • Last update date : August 01, 2019
North America Insulin Pens Market Analysis, Size, and Share by 2027
Report Date: August 01, 2019   |   Report Code: TIPRE00006290 Email: sales@theinsightpartners.com

2018 Market Size

US$ 1,880.7 Mn

Base year value

2027 Forecast

US$ 3,907.9 Mn

Projected by 2027

CAGR 2019-2027

8.7 %

Growth rate

Addressable Market

US$ 26,286.74 Mn

(2019-2027)

The North America insulin pen market is expected to reach US$ 3,907.9 Mn in 2027 from US$ 1,880.7 Mn in 2018.

The market is estimated to grow with a CAGR of 8.7% from 2019-2027. The growth of the market is driven by the factors such as, growing geriatric population and rising incidence of diabetes. However, the market is likely to get impacted due to availability of alternatives for drug delivery and limitations associated with insulin pens in the region.

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipid us and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. In high-income countries up to 91% of adults with the disease have type 2 diabetes.

According to International Diabetes Federation (IDF), approximately 425 million people were living with diabetes in 2017and it is expected to reach 629 million by 2045 across the globe. In 2015, around 9.4% of the population of the U.S. had diabetes, including 30.2 million adults aged 18 years and over. .Additionally, according to Centers for Disease Control and Prevention's report that 4% of people aged 18 to 44 years are living with diabetes, 17 percent of those aged 45 to 64 years, and 25.2 percent of those aged over 65 years are living with diabetes. The following table represents number of patients suffering with diabetes across various North American countries worldwide.

US is expected to lead the market in the North America region owing to rise in the prevalence of the diabetes and growing elder population in the region. However, the country lags behind the other developed countries that can be a restrain to the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.


TIPRE00006290-img1

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA DIABETES CARE DEVICES – MARKET SEGMENTATION

By Product

  • Disposable
  • Reusable

By End User

  • Diabetes Type-1
  • Diabetes Type-2

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

By Geography

  • North America
  • US
  • Canada
  • Mexico


Company Profiles

  • Owen Mumford, LTD.
  • Novo Nordisk a/s
  • Companion Medical
  • Berlin-Chemie AG
  • Pendiq GmbH
  • Emperra GmbH E-Health Technologies
  • Eli lilly and company
  • Ypsomed Ag
  • SANOFI
  • Biocon

North America Insulin Pens Report Scope

Report Attribute Details
Market size in 2018 US$ 1,880.7 Million
Market Size by 2027 US$ 3,907.9 Million
CAGR (2019 - 2027) 8.7%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product Type
  • Disposable and Reusable
By Application
  • Diabetes Type-1 and Diabetes Type-2
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies and e-Commerce
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Owen Mumford, LTD.
  • Novo Nordisk a/s
  • Companion Medical
  • Berlin-Chemie AG
  • Pendiq GmbH
  • Emperra GmbH E-Health Technologies
  • Eli lilly and company
  • Ypsomed Ag
  • SANOFI
  • Biocon
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA